Alpine Immune Sciences
(NASDAQ:ALPN)
$64.57
0[0.00%]
Last update: 9:30AM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Alpine Immune Sciences Stock (NASDAQ:ALPN), Quotes and News Summary

Alpine Immune Sciences Stock (NASDAQ: ALPN) stock price, news, charts, stock research, profile.

Open$64.570
Close-
Volume / Avg.165.835K / 2.246M
Day Range64.550 - 64.600
52 Wk Range6.710 - 64.700
Market Cap$4.233B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
83
Short Interest
13.14%
Days to Cover4.37

Recent News

Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact
Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion, expanding into nephrology with promising APOL1-mediated kidney disease treatments. Analysts foresee significant revenue growth potential, with Alpine's lead molecule poised to add over $5 billion in sales.
Vandana Singh
Stocks Bounce Back With Tech, Gold Gaining After Modest Producer Inflation Data: What's Driving Markets Thursday?
Investors can breathe a sigh of relief on Thursday as last month’s Producer Price Index (PPI) inflation turned out slightly lower than expected, albeit with some caveats across different measures within the basket.
Piero Cingari
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Jan
1
Feb
6
Mar
1
3
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.7
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About Alpine Immune Sciences Inc
Sector
Health Care
Industry
Biotechnology
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company dedicated to discovering an...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ALPN
IMVT

FAQ

Q

How do I buy Alpine Immune Sciences (ALPN) stock?

A

You can purchase shares of Alpine Immune Sciences (NASDAQ: ALPN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Alpine Immune Sciences's (ALPN) competitors?

A

Other companies in Alpine Immune Sciences’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).

Q

What is the target price for Alpine Immune Sciences (ALPN) stock?

A

The latest price target for Alpine Immune Sciences (NASDAQ: ALPN) was reported by TD Cowen on Tuesday, April 16, 2024. The analyst firm set a price target for 0.00 expecting ALPN to fall to within 12 months (a possible -100.00% downside). 30 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Alpine Immune Sciences (ALPN)?

A

The stock price for Alpine Immune Sciences (NASDAQ: ALPN) is $64.59 last updated Today at April 25, 2024 at 9:36 AM EDT.

Q

Does Alpine Immune Sciences (ALPN) pay a dividend?

A

There are no upcoming dividends for Alpine Immune Sciences.

Q

When is Alpine Immune Sciences (NASDAQ:ALPN) reporting earnings?

A

Alpine Immune Sciences’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Q

Is Alpine Immune Sciences (ALPN) going to split?

A

There is no upcoming split for Alpine Immune Sciences.

Q

What sector and industry does Alpine Immune Sciences (ALPN) operate in?

A

Alpine Immune Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch